- Q1 2024 Teva Pharmaceutical Industries Ltd Earnings Call TranscriptMay 08, 2024€15 (+17.65%)Earnings
- Q4 2023 Teva Pharmaceutical Industries Ltd Earnings Call TranscriptJan 31, 2024€11.4 (+7.04%)Earnings
- Teva Pharmaceutical Industries Ltd at JPMorgan Healthcare Conference TranscriptJan 08, 2024
- Q3 2023 Teva Pharmaceutical Industries Ltd Earnings Call TranscriptNov 08, 2023€8.6 (+1.42%)Earnings
- Teva Pharmaceutical Industries Ltd to Discuss the Collaboration with Sanofi to Deliver Inflammatory Bowel Disease Treatment Call TranscriptOct 04, 2023
- Teva Pharmaceutical Industries Ltd at Morgan Stanley Global Healthcare Conference TranscriptSep 11, 2023
- Q2 2023 Teva Pharmaceutical Industries Ltd Earnings Call TranscriptAug 02, 2023€8.5 (+13.94%)Earnings
- Teva Pharmaceutical Industries Ltd Investor Day TranscriptMay 18, 2023
- Q1 2023 Teva Pharmaceutical Industries Ltd Earnings Call TranscriptMay 10, 2023€7.6 (-7.32%)Earnings
- Teva Pharmaceutical Industries Ltd at Barclays Global Healthcare Conference TranscriptMar 14, 2023
- Q4 2022 Teva Pharmaceutical Industries Ltd Earnings Call TranscriptFeb 08, 2023€9.64 (-3.41%)Earnings
- Teva Pharmaceutical Industries Ltd at JPMorgan Healthcare Conference TranscriptJan 11, 2023
- Q3 2022 Teva Pharmaceutical Industries Ltd Earnings Call TranscriptNov 03, 2022€8.94Earnings
- Q2 2022 Teva Pharmaceutical Industries Ltd Earnings Call TranscriptJul 27, 2022€8.6 (+24.64%)Earnings
- Q1 2022 Teva Pharmaceutical Industries Ltd Earnings Call TranscriptMay 03, 2022€8.2 (+0.24%)Earnings
- Q4 2021 Teva Pharmaceutical Industries Ltd Earnings Call TranscriptFeb 09, 2022€7.8 (+6.85%)Earnings
- Teva Pharmaceutical Industries Ltd at JPMorgan Healthcare Conference (Virtual) TranscriptJan 11, 2022
- Q3 2021 Teva Pharmaceutical Industries Ltd Earnings Call TranscriptOct 27, 2021€7.8 (-4.88%)Earnings
- Q2 2021 Teva Pharmaceutical Industries Ltd Earnings Call TranscriptJul 28, 2021€8.65 (+16.42%)Earnings
- Q1 2021 Teva Pharmaceutical Industries Ltd Earnings Call TranscriptApr 28, 2021€8.31 (-4.04%)Earnings
- Teva Pharmaceutical Industries Ltd at JPMorgan Global High Yield & Leveraged Finance Conference (Virtual) TranscriptMar 02, 2021
- Q4 2020 Teva Pharmaceutical Industries Ltd Earnings Call TranscriptFeb 10, 2021€9.85 (-5.65%)Earnings
- Teva Pharmaceutical Industries Ltd at JPMorgan Healthcare Conference (Virtual) TranscriptJan 13, 2021
- Q3 2020 Teva Pharmaceutical Industries Ltd Earnings Call TranscriptNov 05, 2020€7.53 (-5.40%)Earnings
- Q2 2020 Teva Pharmaceutical Industries Ltd Earnings Call TranscriptAug 05, 2020€10.58 (+2.72%)Earnings
- Q1 2020 Teva Pharmaceutical Industries Ltd Earnings Call TranscriptMay 07, 2020€10.8 (+12.50%)Earnings
- Q4 2019 Teva Pharmaceutical Industries Ltd Earnings Call TranscriptFeb 12, 2020€12.24 (+4.79%)Earnings
- Teva Pharmaceutical Industries Ltd at JPMorgan Healthcare Conference TranscriptJan 13, 2020
- Q3 2019 Teva Pharmaceutical Industries Ltd Earnings Call TranscriptNov 07, 2019€7.59 (+1.20%)Earnings
- Q2 2019 Teva Pharmaceutical Industries Ltd Earnings Call TranscriptAug 07, 2019€6.22 (-2.81%)Earnings
- Q1 2019 Teva Pharmaceutical Industries Ltd Earnings Call TranscriptMay 02, 2019€13.25 (-1.85%)Earnings
- Q4 2018 Teva Pharmaceutical Industries Ltd Earnings Call TranscriptFeb 13, 2019€15.75 (-6.53%)Earnings
Q2 2019 Teva Pharmaceutical Industries Ltd Earnings Call Transcript
Good afternoon, ladies and gentlemen, and welcome to the Teva Pharmaceutical Industry's 2nd Quarter Financial results (Operator Instructions). I must advise you that this conference is being recorded today, Wednesday, August 7, 2019 and I would now like to hand the call over to your first speaker today, Kevin Mannix, Senior Vice President, Head of Investor Relations.
Good morning everyone, thanks for joining us today to discuss our 2nd Quarter 2019 financial results. We hope you've had an opportunity to review our earning press release. A copy of the release as well as a copy of the slides being presented on this call can be found on our website at www.tevapharm.com as well as through the Teva Investor Relations app.
Please note that the discussion on today's call includes certain non-GAAP measures that are defined by the SEC. Management uses both GAAP financial measures and the disclosed non-GAAP financial measures
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)